Analysis Life Sciences Thank You What We Expect the FDA to do in August and September 2024
Agency IQ
AUGUST 2, 2024
Title Type Date Received by OIRA Legal Deadline Expedited Program for Serious Conditions –Accelerated Approval of Drugs and Biologics Draft Guidance July 9 Yes Conducting Clinical Trials With Decentralized Elements Draft Guidance July 25 Yes Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice Draft (..)
Let's personalize your content